{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:33:07Z","timestamp":1780471987071,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Commission of Shanghai Municipality"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To compare the prognosis of lymphatic metastasis in type I and type II epithelial ovarian cancer (OC) and to identify the risk factors for pelvic lymph node metastases (PLNs) and para-aortic lymph node metastases (PALNs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients diagnosed with epithelial OC were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Overall survival (OS) and cancer-specific survival (CSS) were estimated. The Cox proportional hazards regression model was used to identify independent predictors of survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 11,275 patients with OC were enrolled, including 31.2% with type I and 68.8% with type II. Type II and high tumour stage were risk factors for lymph node involvement (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The overall rate of lymph node metastasis in type I was 11.8%, and that in type II was 36.7%. In the type I group, the lymph node metastasis rates in stages T1, T2, T3 and T<jats:sub>X<\/jats:sub>M<jats:sub>1<\/jats:sub> were 3.2%, 14.5%, 40.4% and 50.0%, respectively. In the type II group, these rates were 6.4%, 20.4%, 54.1% and 61.1%, respectively. Age and tumour size had little effect on lymph node metastasis, and grade 3 was not always a risk factor. For the type I group, the 10-year CSS rates of LN(-), PLN(\u2009+), PALN(\u2009+), and PLN\u2009+\u2009PALN(\u2009+) were 80.6%, 46.6%, 36.3%, and 32.3%, respectively. The prognosis of PLN (\u2009+) was better than that of PALN (\u2009+) in the type I group (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). For the type II group, the 10-year CSS rates of LN(-), PLN(\u2009+), PALN(\u2009+), and PLN\u2009+\u2009PALN(\u2009+) were 55.6%, 18.5%, 25.7%, and 18.2%, respectively. PALN (\u2009+) had a significantly better prognosis than PLN (\u2009+) in the type II group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The clinical characteristics and prognoses of patients with type I and type II OC differed greatly. Patients with type II and higher tumour stages had poorer prognoses. Type I with PALN metastasis and type II with PLN metastasis indicated a worse prognosis. Patients with stage TI did not require lymph node dissection, especially in the type I group.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01102-8","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:03:27Z","timestamp":1675055007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Hailin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"issue":"5","key":"1102_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"I Shih","year":"2004","unstructured":"Shih I, Kurman RJ. Ovarian tumorigenesis: A proposed model based on morphological and molecular genetic analysis[J]. Am J Pathol. 2004;164(5):1511\u20138.","journal-title":"Am J Pathol"},{"issue":"3","key":"1102_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/IGC.0b013e3181cf6271","volume":"20","author":"H Nomura","year":"2010","unstructured":"Nomura H, Tsuda H, Susumu N, et al. Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer[J]. Int J Gynecol Cancer. 2010;20(3):341\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"1102_CR3","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/IGC.0b013e3181b8a07c","volume":"19","author":"M Fournier","year":"2009","unstructured":"Fournier M, Stoeckle E, Guyon F, et al. Lymph node involvement in epithelial ovarian cancer: Sites and risk factors in a series of 355 patients. Int J Gynecol Cancer. 2009;19(8):1307\u201313.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"1102_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/sj.bjc.6603323","volume":"95","author":"A Maggioni","year":"2006","unstructured":"Maggioni A, Benedetti PP, Dell\u2019anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95(6):699\u2013704.","journal-title":"Br J Cancer"},{"issue":"8","key":"1102_CR5","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.jmig.2020.12.030","volume":"28","author":"E Matanes","year":"2021","unstructured":"Matanes E, Gupta V, Kogan L, et al. Surgical technique for sentinel lymph node sampling in presumed early-stage ovarian cancer. J Minim Invasive Gynecol. 2021;28(8):1446.","journal-title":"J Minim Invasive Gynecol"},{"issue":"3","key":"1102_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/medicina56030108","volume":"56","author":"N Bacalbasa","year":"2020","unstructured":"Bacalbasa N, Balescu I, Vilcu M, et al. The risk of Para-Aortic lymph node metastases in apparent early stage ovarian cancer. Medicina (Kaunas). 2020;56(3):108.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"1102_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13048-021-00887-w","volume":"14","author":"P Laven","year":"2021","unstructured":"Laven P, Kruitwagen R, Zusterzeel P, et al. Sentinel lymph node identification in early stage ovarian cancer: Is it still possible after prior tumor resection?[J]. J Ovarian Res. 2021;14(1):132.","journal-title":"J Ovarian Res"},{"key":"1102_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fonc.2020.00355","volume":"10","author":"A Cheng","year":"2020","unstructured":"Cheng A, Lang J. Survival Analysis of lymph node resection in ovarian cancer: A Population-Based study. Front Oncol. 2020;10:355.","journal-title":"Front Oncol"},{"issue":"3","key":"1102_CR9","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.3802\/jgo.2021.32.e40","volume":"32","author":"T Deng","year":"2021","unstructured":"Deng T, Huang Q, Wan T, et al. The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer[J]. J Gynecol Oncol. 2021;32(3):e40.","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"1102_CR10","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms[J]. N Engl J Med. 2019;380(9):822\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"1102_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1072-7515(03)00234-5","volume":"197","author":"P Morice","year":"2003","unstructured":"Morice P, Joulie F, Camatte S, et al. Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg. 2003;197(2):198\u2013205.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"1102_CR12","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.3802\/jgo.2021.32.e61","volume":"32","author":"M Imterat","year":"2021","unstructured":"Imterat M, Harter P. Early-stage epithelial ovarian cancer: Is systematic lymph node staging mandatory? J Gynecol Oncol. 2021;32(4):e61.","journal-title":"J Gynecol Oncol"},{"issue":"36","key":"1102_CR13","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.2217\/fon-2021-0419","volume":"17","author":"D Atallah","year":"2021","unstructured":"Atallah D, Arab W, Dagher B, et al. Predictive factors of lymph node metastasis and pattern of repartition in patients with epithelial ovarian cancer. Future Oncol. 2021;17(36):5093\u2013101.","journal-title":"Future Oncol"},{"key":"1102_CR14","doi-asserted-by":"publisher","first-page":"705720","DOI":"10.3389\/fonc.2021.705720","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Yin J, Li Y, et al. Systematic lymph node dissection may be abolished in patients with apparent Early-Stage Low-Grade mucinous and endometrioid epithelial ovarian cancer. Front Oncol. 2021;11:705720.","journal-title":"Front Oncol"},{"issue":"5","key":"1102_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00404-013-3078-3","volume":"289","author":"V Ulker","year":"2014","unstructured":"Ulker V, Kuru O, Numanoglu C, et al. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: Review of a single-institution experience. Arch Gynecol Obstet. 2014;289(5):1087\u201392.","journal-title":"Arch Gynecol Obstet"},{"key":"1102_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijsu.2017.08.586","volume":"46","author":"RA Agha","year":"2017","unstructured":"Agha RA, Borrelli MR, Vella-Baldacchino M, et al. The STROCSS statement: Strengthening the reporting of cohort studies in surgery. Int J Surg. 2017;46:198\u2013202.","journal-title":"Int J Surg"},{"issue":"3","key":"1102_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1525-1438.2003.13192.x","volume":"13","author":"S Tangjitgamol","year":"2003","unstructured":"Tangjitgamol S, Manusirivithaya S, Sheanakul C, et al. Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma? Int J Gynecol Cancer. 2003;13(3):297\u2013302.","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"1102_CR18","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/jjco\/hyaa124","volume":"50","author":"T Mitamura","year":"2020","unstructured":"Mitamura T, Sekine M, Arai M, et al. Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome. Jpn J Clin Oncol. 2020;50(12):1380\u20135.","journal-title":"Jpn J Clin Oncol"},{"key":"1102_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijsu.2016.03.039","volume":"29","author":"J Zhou","year":"2016","unstructured":"Zhou J, Sun JY, Wu SG, et al. Risk factors for lymph node metastasis in ovarian cancer: Implications for systematic lymphadenectomy. Int J Surg. 2016;29:123\u20137.","journal-title":"Int J Surg"},{"issue":"3","key":"1102_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ygyno.2011.05.001","volume":"122","author":"CA Powless","year":"2011","unstructured":"Powless CA, Aletti GD, Bakkum-Gamez JN, et al. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: Implications for surgical staging. Gynecol Oncol. 2011;122(3):536\u201340.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1102_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ygyno.2016.02.017","volume":"141","author":"BC Cox","year":"2016","unstructured":"Cox BC, Greer DM, Kram J, et al. Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer. Gynecol Oncol. 2016;141(2):199\u2013205.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1102_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/gyno.2000.5951","volume":"79","author":"M Suzuki","year":"2000","unstructured":"Suzuki M, Ohwada M, Yamada T, et al. Lymph node metastasis in stage I epithelial ovarian cancer. Gynecol Oncol. 2000;79(2):305\u20138.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1102_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ygyno.2005.06.051","volume":"99","author":"N Takeshima","year":"2005","unstructured":"Takeshima N, Hirai Y, Umayahara K, et al. Lymph node metastasis in ovarian cancer: Difference between serous and non-serous primary tumors. Gynecol Oncol. 2005;99(2):427\u201331.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1102_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ygyno.2011.09.013","volume":"123","author":"M Kleppe","year":"2011","unstructured":"Kleppe M, Wang T, Van Gorp T, et al. Lymph node metastasis in stages I and II ovarian cancer: A review. Gynecol Oncol. 2011;123(3):610\u20134.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1102_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11684-014-0316-4","volume":"8","author":"X Li","year":"2014","unstructured":"Li X, Xing H, Li L, et al. Clinical significance of para-aortic lymph node dissection and prognosis in ovarian cancer. Front Med. 2014;8(1):96\u2013100.","journal-title":"Front Med"},{"issue":"4","key":"1102_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3892\/mco.2016.982","volume":"5","author":"C Bachmann","year":"2016","unstructured":"Bachmann C, Bachmann R, Kraemer B, et al. Prevalence and distribution pattern of nodal metastases in advanced ovarian cancer. Mol Clin Oncol. 2016;5(4):483\u20137.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"1102_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3802\/jgo.2013.24.1.29","volume":"24","author":"SJ Chang","year":"2013","unstructured":"Chang SJ, Bristow RE, Ryu HS. Analysis of para-aortic lymphadenectomy up to the level of the renal vessels in apparent early-stage ovarian cancer. J Gynecol Oncol. 2013;24(1):29\u201336.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"1102_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih I. The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am J Surg Pathol. 2010;34(3):433\u201343.","journal-title":"Am J Surg Pathol"},{"key":"1102_CR29","doi-asserted-by":"publisher","first-page":"934261","DOI":"10.1155\/2014\/934261","volume":"2014","author":"M Koshiyama","year":"2014","unstructured":"Koshiyama M, Matsumura N, Konishi I. Recent concepts of ovarian carcinogenesis: Type I and type II. Biomed Res Int. 2014;2014:934261.","journal-title":"Biomed Res Int"},{"issue":"3","key":"1102_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/PAT.0b013e32835f2264","volume":"45","author":"D Lim","year":"2013","unstructured":"Lim D, Oliva E. Precursors and pathogenesis of ovarian carcinoma. Pathology. 2013;45(3):229\u201342.","journal-title":"Pathology"},{"issue":"5","key":"1102_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih I, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: Pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009;16(5):267\u201382.","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"1102_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","volume":"186","author":"RJ Kurman","year":"2016","unstructured":"Kurman RJ, Shih I. The dualistic model of ovarian carcinogenesis: Revisited, revised, and expanded. Am J Pathol. 2016;186(4):733\u201347.","journal-title":"Am J Pathol"},{"issue":"2","key":"1102_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ygyno.2010.07.026","volume":"119","author":"E Senturk","year":"2010","unstructured":"Senturk E, Cohen S, Dottino PR, et al. A critical re-appraisal of BRCA1 methylation studies in ovarian cancer. Gynecol Oncol. 2010;119(2):376\u201383.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1102_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/GRF.0b013e31824b1725","volume":"55","author":"CP Crum","year":"2012","unstructured":"Crum CP, Mckeon FD, Xian W. The oviduct and ovarian cancer: Causality, clinical implications, and \u201ctargeted prevention.\u201d Clin Obstet Gynecol. 2012;55(1):24\u201335.","journal-title":"Clin Obstet Gynecol"},{"issue":"2","key":"1102_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ygyno.2014.02.011","volume":"133","author":"R Vargas","year":"2014","unstructured":"Vargas R, Rauh-Hain JA, Clemmer J, et al. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: A SEER analysis. Gynecol Oncol. 2014;133(2):216\u201320.","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01102-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01102-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01102-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:07:35Z","timestamp":1675055255000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01102-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01102-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"23 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There were no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}